vorasidenib
servier
['indigo', 'caveat']
also excellent discussion of limitations and caveats. limitations were not even discussed for the earlier indigo trial. #asco23 
Personal account. Med Onc. Associate Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: https://t.co/FTRPKNykq3 Talks- https://t.co/anav3AIZjO